Newsroom

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will report financial results for the first quarter ended March 31, 2025, after […]

read more +
Sight Sciences Announces the Release of its Sustainability Report

The Sustainability Report provides data for 2022 through 2024 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that it has published […]

read more +
Sight Sciences Appoints Gary Burbach to its Board of Directors

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that Gerhard (Gary) F. Burbach was appointed to the Company’s Board of Directors on April 21, […]

read more +
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

<div class=”ndq-section”> <div id=”ndq-content” class=”row ndq-9211″> <div class=”column large-12″> <div class=”region region-content”> <div data-drupal-messages-fallback=”” class=”hidden”></div> <div id=”block-nir-pid4158-content” class=”block–system-main-block block–system-main-block–9211 block–content–system-main-block block–content–system-main-block–9211 block–d3e5cab3-701e-469f-8150-a0c2ef34d4c7 block–d3e5cab3-701e-469f-8150-a0c2ef34d4c7–9211 block block-system block-system-main-block”> <article class=”node node–nir-news–full node–type-nir-news node–view-mode-full node–promoted”>   <div class=”file-link pdf-file-link”> <span class=”file file–mime-application-pdf file–application-pdf”><a href=”/wp-content/uploads/sites/4/2024/10/Sight-Sciences-to-Report-Third-Quarter-Financial-Results-on-November-7-2024.pdf” type=”application/pdf” target=”_blank” rel=”noopener”>PDF Version</a></span> </div> <div class=”node__content”> <div class=”box__wrap”> </div> <p align=”justify”>MENLO PARK, Calif., […]

read more +
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

PDF Version MENLO PARK, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the second quarter ended June 30, 2024, and narrowed financial guidance […]

read more +
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

PDF Version MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced that it will present at the upcoming Morgan Stanley Global Healthcare Conference, in New […]

read more +
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

MENLO PARK, Calif., July 18, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the second quarter ended June 30, 2024, after the market […]

read more +
Sight Sciences Announces the Release of its First Sustainability Report

PDF Version The Sustainability Report provides data for 2021 through 2023 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of […]

read more +
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

PDF Version The analysis published in Clinical Ophthalmology suggests that OMNI was as effective at lowering IOP and reducing medication usage in advanced glaucoma as it was in mild and moderate glaucoma. MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company […]

read more +